India vaccinates more than 100 crore people
More than 61lLakh doses administered in the last 24 hours
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European Medicines Agency (EMA) added GBS as…
Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine
First results from any randomised, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6 per…
Adar Poonawalla says Serum might export 20-30 million vaccine doses a month to COVAX
Poonawalla said the company's production of the vaccine could go up to 240 million doses a month from around 220 million now
Vaccines offer strong protection against death from COVID-19 Delta variant
The research, involving the University of Strathclyde, has found that the Pfizer-BioNTech vaccine is 90 per cent effective and the…
FDA takes additional actions on use of booster dose for COVID-19 vaccines
The US health regulator talks about using single booster dose of the vaccines developed by Moderna, Johnson & Johnson and…
Gates Foundation allots $120 million for poor nations to get COVID-19 drug
The money will support efforts to develop and make generic versions of what could become the first oral antiviral medication for…
WHO Chief discusses Covaxin and resumption of AstraZeneca vaccine supply to COVAX facility with…
COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable access of…
NIH grants accreditation to immunoseb, probioseb CSC3 effective supplements to resolve ‘long…
A panel of experts set up by the NIH recently published a fact sheet, which endorsed the fact that there is satisfactory clinical…
WHO-led programme plans to purchase anti-viral COVID-19 pills for $10
Merck's experimental pill Molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being…
Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate…
VLA2001 was well-tolerated, demonstrating a statistically significant better tolerability profile compared to active comparator…
mRNA COVID jabs as second dose may generate robust immune response: Lancet study
The study, published in the journal The Lancet Regional Health - Europe, points out the high effectiveness of mix-and-match…
Pfizer/BioNTech submit data to EMA for children’s COVID-19 vaccine
Although the vaccine is currently not allowed for that age group, it has been authorised for use in children over 12 years of age…
Merck’s COVID pill sparks calls for access for poor countries
The firm has taken the unusual pandemic step of licensing several generics of its antiviral Molnupiravir before its branded…
Over 30 countries agree on mutual recognition of COVID-19 vaccine certificates with India, reveal…
The countries that have agreed on mutual recognition with India include the UK, France, Germany, Nepal, Belarus, Lebanon, Armenia,…
US FDA advisers to review Merck’s Molnupiravir soon
The US FDA's panel will meet on 30th November, 2021 to discuss the safety and effectiveness of Molnupiravir for the treatment of…
India resumes vaccine exports as domestic stocks build up: Officials
So far, about four million shots have been exported
One-shot Sputnik Light vaccine demonstrates 70 per cent efficacy against Delta variant: Gamaleya…
The vaccine is more than 75 per cent effective among subjects under the age of 60. Sputnik Light also provides much higher…
Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those…
Currently, phase-II/III clinical trials of the second indigenously developed Corbevax is underway and the results are likely to be…
Everest Organics starts making ingredient for Merck’s COVID-19 pill
The bulk drugs manufacturer joins Divi's Laboratories as an API maker for Merck's experimental oral drug